NCCN Guidelines Insights: Melanoma, Version 3.2016.

Journal Article (Journal Article)

The NCCN Guidelines for Melanoma have been significantly revised over the past few years in response to emerging data on a number of novel agents and treatment regimens. These NCCN Guidelines Insights summarize the data and rationale supporting extensive changes to the recommendations for systemic therapy in patients with metastatic or unresectable melanoma.

Full Text

Duke Authors

Cited Authors

  • Coit, DG; Thompson, JA; Algazi, A; Andtbacka, R; Bichakjian, CK; Carson, WE; Daniels, GA; DiMaio, D; Fields, RC; Fleming, MD; Gastman, B; Gonzalez, R; Guild, V; Johnson, D; Joseph, RW; Lange, JR; Martini, MC; Materin, MA; Olszanski, AJ; Ott, P; Gupta, AP; Ross, MI; Salama, AK; Skitzki, J; Swetter, SM; Tanabe, KK; Torres-Roca, JF; Trisal, V; Urist, MM; McMillian, N; Engh, A

Published Date

  • August 2016

Published In

Volume / Issue

  • 14 / 8

Start / End Page

  • 945 - 958

PubMed ID

  • 27496110

Electronic International Standard Serial Number (EISSN)

  • 1540-1413

Digital Object Identifier (DOI)

  • 10.6004/jnccn.2016.0101


  • eng

Conference Location

  • United States